"We need to make sure current, well-established stem cell therapies, such as ordinary bone marrow transplants, do not require physicians to undertake a review and approval process by an institutional review board," Dr. Malone wrote in a formal TMA comment letter to TMB. "Bone marrow, peripheral blood stem cells, and cord blood are all used in transplants for hematopoietic reconstitution (usually referred to generically as bone marrow transplants)."
Action, Nov. 1, 2011
Last Updated On
June 20, 2016
Originally Published On
October 31, 2011